MTM Investment Management’s Boston Scientific BSX Stock Holding History

MTM Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Buy	5,197 +100	+2%	+$5.43K	0.06%	205
2026 Q1	$320K	Hold	5,097	–	–	0.1%	163
2025 Q4	$486K	Hold	5,097	–	–	0.16%	125
2025 Q3	$498K	Sell	5,097 -675	-12%	-$69.9K	0.16%	129
2025 Q2	$620K	Hold	5,772	–	–	0.21%	106
2025 Q1	$584K	Hold	5,772	–	–	0.23%	105
2024 Q4	$516K	Buy	5,772 +150	+3%	+$13.2K	0.2%	116
2024 Q3	$475K	Hold	5,622	–	–	0.19%	122
2024 Q2	$433K	Hold	5,622	–	–	0.18%	119
2024 Q1	$385K	Buy	5,622 +67	+1%	+$4.31K	0.16%	130
2023 Q4	$321K	Hold	5,555	–	–	0.15%	134
2023 Q3	$293K	Hold	5,555	–	–	0.15%	129
2023 Q2	$300K	Hold	5,555	–	–	0.15%	135
2023 Q1	$278K	Hold	5,555	–	–	0.14%	143
2022 Q4	$257K	Hold	5,555	–	–	0.13%	152
2022 Q3	$215K	Hold	5,555	–	–	0.12%	159
2022 Q2	$211K	Hold	5,555	–	–	0.11%	163
2022 Q1	$246K	Hold	5,555	–	–	0.12%	154
2021 Q4	$236K	Hold	5,555	–	–	0.11%	166
2021 Q3	$241K	Hold	5,555	–	–	0.13%	143
2021 Q2	$238K	Hold	5,555	–	–	0.12%	146
2021 Q1	$215K	Hold	5,555	–	–	0.12%	148
2020 Q4	$200K	Buy	+5,555	New	+$200K	0.12%	142

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MTM Investment Management's BSX Position: Q2 2026 in Review

MTM Investment Management increased its Boston Scientific (BSX) stake by 2% in Q2 2026, buying an estimated $5.43K and bringing the position to 5,197 shares worth $222K. The position accounts for 0.06% of the portfolio, ranked #205.

MTM Investment Management first reported a position in BSX in Q4 2020 and has held it in 23 quarters since. The position peaked at $620K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

MTM Investment Management held 5,197 shares of Boston Scientific worth $222K as of Q2 2026.
MTM Investment Management bought 100 Boston Scientific shares in Q2 2026, an estimated $5.43K.
Boston Scientific made up 0.06% of MTM Investment Management's portfolio in Q2 2026, its #205 holding.
MTM Investment Management first reported a position in Boston Scientific in Q4 2020 and has held it in 23 quarters since.
MTM Investment Management's Boston Scientific position peaked at $620K in Q2 2025.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.